ProfileGDS4459 / ENSG00000183307
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 38% 42% 50% 48% 45% 39% 56% 43% 45% 45% 34% 46% 51% 49% 41% 55% 56% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.0438
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.1642
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.3750
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.4248
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.245
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 6439
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.7156
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.0843
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.1645
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.2245
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.7434
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.2246
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.4551
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.449
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.9741
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.5855
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.656